Update on the role of vitamin K in skeletal health

Nutrition Reviews

Volumn 66, Issue 10, 2008, Pages 549-557

  Shea, M Kyla ^a   Booth, Sarah L ^a  

^a TUFTS UNIVERSITY   (United States)

Author keywords

Bone mineral density; Fracture; Menaquinone; Phylloquinone; Vitamin K

Indexed keywords

CALCIUM; MENATETRENONE; PHYTOMENADIONE; PLACEBO; VITAMIN D; VITAMIN K GROUP;

BONE MASS; BONE TURNOVER; DIET SUPPLEMENTATION; DRUG EFFICACY; FEMUR NECK FRACTURE; FOOD INTAKE; HEALTH STATUS; HIP FRACTURE; HUMAN; LEGUME; METACARPAL BONE FRACTURE; OSTEOLYSIS; REVIEW; SPINE; TREATMENT FAILURE; VEGETABLE; VITAMIN K DEFICIENCY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BONE AND BONES; BONE DENSITY; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN K; VITAMIN K 1; VITAMIN K DEFICIENCY;

EID: 52649099382     PISSN: 00296643     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1753-4887.2008.00106.x     Document Type: Review

References (87)

1. 1) among British adults in 1986-7 and 2000-1. Br J Nutr. 2006 96: 1105 1115.
2. Kamao M, Suhara Y, Tsugawa N, et al. Vitamin K content of foods and dietary vitamin K intake in Japanese young women. J Nutr Sci Vitaminol (Tokyo). 2007 53: 464 470.
3. 2) in mice: two possible routes for menaquinone-4 accumulation in cerebra of mice. J Biol Chem. 2008 283: 11270 11279.
4. Elder SJ, Haytowitz DB, Howe J, Peterson JW, Booth SL. Vitamin K contents of meat, dairy, and fast food in the US diet. J Agric Food Chem. 2006 54: 463 467.
5. 2 (menaquinone) in the Netherlands. J Nutr Environ Medicine. 1999 9: 115 122.
6. 2)-7 by Bacillus subtilis. J Biosci Bioeng. 2001 91: 16 20.
7. Standing Committee on Scientific Evaluation of Dietary Reference Intakes, Food and Nutrition Board, Institute of Medicine. Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc. A report of the Panel on Micronutrients. Washington DC: National Academy Press 2000.
8. Binkley NC, Krueger DC, Kawahara TN, Engelke JA, Chappell RJ, Suttie JW. A high phylloquinone intake is required to achieve maximal osteocalcin gamma-carboxylation. Am J Clin Nutr. 2002 76: 1055 1060.
9. Booth SL, Broe KE, Gagnon DR, et al. Vitamin K intake and bone mineral density in women and men. Am J Clin Nutr. 2003 77: 512 516.
10. Booth SL, Al Rajabi A. Determinants of vitamin K status in humans. Vitam Horm. 2008 78: 1 22.
11. Booth SL, O'Brien-Morse ME, Dallal GE, Davidson KW, Gundberg CM. Response of vitamin K status to different intakes and sources of phylloquinone-rich foods: comparison of younger and older adults. Am J Clin Nutr. 1999 70: 368 377.
12. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr. 1998 128: 785 788.
13. Shea MK, Benjamin EJ, Dupuis J, et al. Genetic and non-genetic correlates of vitamins K and D. Eur J Clin Nutr. 2007 Epub ahead of print).
14. Gundberg CM, Nieman SD, Abrams S, Rosen H. Vitamin K status and bone health: an analysis of methods for determination of undercarboxylated osteocalcin. J Clin Endocrinol Metab. 1998 83: 3258 3266.
15. Sokoll LJ, Booth SL, O'Brien ME, Davidson KW, Tsaioun KI, Sadowski JA. Changes in serum osteocalcin, plasma phylloquinone, and urinary gamma-carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects. Am J Clin Nutr. 1997 65: 779 784.
16. Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G. Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone. 1998 23: 187 196.
17. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature. 1996 382: 448 452.
18. Arbour NC, Darwish HM, DeLuca HF. Transcriptional control of the osteocalcin gene by 1,25-dihydroxyvitamin D-2 and its 24-epimer in rat osteosarcoma cells. Biochim Biophys Acta. 1995 1263:147 153.
19. Cairns JR, Williamson MK, Price PA. Direct identification of gamma-carboxyglutamic acid in the sequencing of vitamin K-dependent proteins. Anal Biochem. 1991 199:93 97.
20. Nakao M, Nishiuchi Y, Nakata M, Kimura T, Sakakibara S. Synthesis of human osteocalcins: gamma-carboxyglutamic acid at position 17 is essential for a calcium-dependent conformational transition. Pept Res. 1994 7:171 174.
21. Kohlmeier M, Salomon A, Saupe J, Shearer MJ. Transport of vitamin K to bone in humans. J Nutr. 1996 126 (Suppl S1192 S1196.
22. Zajickova K, Zofkova I, Hill M, Horinek A, Novakova A. Apolipoprotein E 4 allele is associated with low bone density in postmenopausal women. J Endocrinol Invest. 2003 26:312 315.
23. Johnston JM, Cauley JA, Ganguli M. APOE 4 and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc. 1999 47:1342 1345.
24. Cauley JA, Zmuda JM, Yaffe K, et al. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk - The Study of Osteoporotic Fractures. J Bone Miner Res. 1999 14:1175 1181.
25. Schoofs MW, van der Klift M, Hofman A, et al. ApoE gene polymorphisms, BMD, and fracture risk in elderly men and women: the Rotterdam study. J Bone Miner Res. 2004 19:1490 1496.
26. 3-induced mineralization in human periosteal osteoblasts. Calcif Tissue Int. 1996 59:466 473.
27. 2 (menatetrenone) on bone resorption may be related to its side chain. Bone. 1995 16:179 184.
28. 2 inhibits osteoclastic bone resorption by inducing osteoclast apoptosis. Biochem Biophys Res Commun. 1996 220:515 519.
29. Katsuyama H, Otsuki T, Tomita M, et al. Menaquinone-7 regulates the expressions of osteocalcin, OPG, RANKL and RANK in osteoblastic MC3T3E1 cells. Int J Mol Med. 2005 15:231 236.
30. Reddi K, Henderson B, Meghji S, et al. Interleukin 6 production by lipopolysaccharide-stimulated human fibroblasts is potently inhibited by naphthoquinone (vitamin K) compounds. Cytokine. 1995 7:287 290.
31. Shea MK, Booth SL, Massaro JM, et al. Vitamin K and vitamin D status: associations with inflammatory markers in the Framingham Offspring Study. Am J Epidemiol. 2008 167:313 320.
32. 2 regulation of bone homeostasis is mediated by the steroid and xenobiotic receptor SXR. J Biol Chem. 2003 278:43919 43927.
33. 2-activated transcription of extracellular matrix-related genes and collagen accumulation in osteoblastic cells. J Biol Chem. 2006 281:16927 16934.
34. Feskanich D, Weber P, Willett WC, Rockett H, Booth SL, Colditz GA. Vitamin K intake and hip fractures in women: a prospective study. Am J Clin Nutr. 1999 69:74 79.
35. Booth SL, Tucker KL, Chen H, et al. Dietary vitamin K intakes are associated with hip fracture but not with bone mineral density in elderly men and women. Am J Clin Nutr. 2000 71:1201 1208.
36. 1 intake is associated with higher bone mineral density and reduced bone resorption in early postmenopausal Scottish women: no evidence of gene-nutrient interaction with apolipoprotein E polymorphisms. Am J Clin Nutr. 2008 87:1513 1520.
37. Ashwell M, Stone E, Mathers J, et al. Nutrition and bone health projects funded by the UK Food Standards Agency: have they helped to inform public health policy? Br J Nutr. 2008 99:198 205.
38. Ikeda Y, Iki M, Morita A, et al. Intake of fermented soybeans, natto, is associated with reduced bone loss in postmenopausal women: Japanese Population-Based Osteoporosis (JPOS) Study. J Nutr. 2006 136:1323 1328.
39. Katsuyama H, Ideguchi S, Fukunaga M, Saijoh K, Sunami S. Usual dietary intake of fermented soybeans (Natto) is associated with bone mineral density in premenopausal women. J Nutr Sci Vitaminol (Tokyo). 2002 48:207 215.
40. Yaegashi Y, Onoda T, Tanno K, Kuribayashi T, Sakata K, Orimo H. Association of hip fracture incidence and intake of calcium, magnesium, vitamin D, and vitamin K. Eur J Epidemiol. 2008 23:219 225.
41. Luukinen H, Kakonen SM, Pettersson K, et al. Strong prediction of fractures among older adults by the ratio of carboxylated to total serum osteocalcin. J Bone Miner Res. 2000 15:2473 2478.
42. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture in elderly women. J Clin Invest. 1993 91:1769 1774.
43. Vergnaud P, Garnero P, Meunier PJ, Breart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab. 1997 82:719 724.
44. Tsugawa N, Shiraki M, Suhara Y, et al. Low plasma phylloquinone concentration is associated with high incidence of vertebral fracture in Japanese women. J Bone Miner Metab. 2008 26:79 85.
45. Liu G, Peacock M. Age-related changes in serum undercarboxylated osteocalcin and its relationships with bone density, bone quality, and hip fracture. Calcif Tissue Int. 1998 62:286 289.
46. 1, menaquinone-4, and menaquinone-7 in healthy elderly Japanese women and patients with vertebral fractures and patients with hip fractures. Endocr Res. 2001 27:337 343.
47. Fewtrell MS, Benden C, Williams JE, et al. Undercarboxylated osteocalcin and bone mass in 8-12 year old children with cystic fibrosis. J Cyst Fibros. 2008 7:307 312.
48. O'Connor E, Molgaard C, Michaelsen KF, Jakobsen J, Lamberg-Allardt CJ, Cashman KD. Serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, and its relationship to bone health indices in Danish girls. Br J Nutr. 2007 97:661 666.
49. van Summeren MJ, Van Coeverden SC, Schurgers LJ, et al. Vitamin K status is associated with childhood bone mineral content. Br J Nutr. 2008:1 7.
50. Conway SP, Wolfe SP, Brownlee KG, et al. Vitamin K status among children with cystic fibrosis and its relationship to bone mineral density and bone turnover. Pediatrics. 2005 115:1325 1331.
51. Kalkwarf HJ, Khoury JC, Bean J, Elliot JG. Vitamin K, bone turnover, and bone mass in girls. Am J Clin Nutr. 2004 80:1075 1080.
52. Lukacs JL, Booth S, Kleerekoper M, Ansbacher R, Rock CL, Reame NE. Differential associations for menopause and age in measures of vitamin K, osteocalcin, and bone density: a cross-sectional exploratory study in healthy volunteers. Menopause. Aug 11 2006 13:799 808.
53. Yasui T, Uemura H, Tomita J, et al. Change in serum undercarboxylated osteocalcin concentration in bilaterally oophorectomized women. Maturitas. 2007 56:288 296.
54. Yasui T, Uemura H, Tomita J, et al. Different effects of oral conjugated equine estrogens and transdermal estrogen on undercarboxylated osteocalcin concentration in postmenopausal women. Menopause. 2006 13:651 659.
55. Braam LA, Knapen MH, Geusens P, Brouns F, Vermeer C. Factors affecting bone loss in female endurance athletes: a two-year follow-up study. Am J Sports Med. 2003 31:889 895.
56. Bolton-Smith C, McMurdo ME, Paterson CR, et al. Two-year randomized controlled trial of vitamin K(1) (phylloquinone) and vitamin D(3) plus calcium on the bone health of older women. J Bone Miner Res. 2007 22:509 519.
57. Booth SL, Dallal G, Shea MK, Gundberg C, Peterson JW, Dawson-Hughes B. Effect of vitamin K supplementation on bone loss in elderly men and women. J Clin Endocrinol Metab. 2008 93:1217 1223.
58. 1 supplementation retards bone loss in postmenopausal women between 50 and 60 years of age. Calcif Tissue Int. 2003 73:21 26.
59. Harke JM, Krueger D, Gemar D, Binkley N. Vitamin K treatment reduces undercarboxylated osteocalcin but does not alter bone turnover or density in postmenopausal North American women [abstract]. JBMR. 2005 20 (Suppl S288.
60. 2) and bone quality in the treatment of postmenopausal osteoporosis. Nutr Rev. 2006 64:509 517.
61. Hidaka T, Hasegawa T, Fujimura M, Sakai M, Saito S. Treatment for patients with postmenopausal osteoporosis who have been placed on HRT and show a decrease in bone mineral density: effects of concomitant administration of vitamin K(2). J Bone Miner Metab. 2002 20:235 239.
62. 2 (menatetrenone) treatment in children treated with glucocorticoid and alfacalcidol. Endocr J. 2001 48:11 18.
63. Ishida Y, Kawai S. Comparative efficacy of hormone replacement therapy, etidronate, calcitonin, alfacalcidol, and vitamin K in postmenopausal women with osteoporosis: The Yamaguchi Osteoporosis Prevention Study. Am J Med. 2004 117:549 555.
64. 3 and estrogen-progestin therapy. Maturitas. 1999 31:161 164.
65. 2 on bone mineral density of the lumbar spine in postmenopausal women with osteoporosis. J Orthop Sci. 2000 5:546 551.
66. Iwamoto J, Takeda T, Ichimura S. Effect of menatetrenone on bone mineral density and incidence of vertebral fractures in postmenopausal women with osteoporosis: a comparison with the effect of etidronate. J Orthop Sci. 2001 6:487 492.
67. 2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women. Osteoporos Int. 2007 18:963 972.
68. 2 (menatetrenone) on bone metabolism in postmenopausal women. Endocr J. 2002 49:363 370.
69. 2 treatment for postmenopausal osteoporosis in Indonesia. J Obstet Gynaecol Res. 2006 32:230 234.
70. 2 inhibits glucocorticoid-induced bone loss partly by preventing the reduction of osteoprotegerin (OPG). J Bone Miner Metab. 2005 23:41 47.
71. Sato Y, Honda Y, Kaji M, et al. Amelioration of osteoporosis by menatetrenone in elderly female Parkinson's disease patients with vitamin D deficiency. Bone. 2002 31:114 118.
72. 2 with calcium supplements prevent nonvertebral fracture in elderly women with Alzheimer's disease. Bone. 2005 36:61 68.
73. 2 (menatetrenone) for bone loss in patients with cirrhosis of the liver. Am J Gastroenterol. 2002 97:978 981.
74. 2 (menatetrenone) effectively prevents fractures and sustains lumbar bone mineral density in osteoporosis. J Bone Miner Res. 2000 15:515 521.
75. 3 in the prevention of bone loss induced by leuprolide. J Clin Endocrinol Metab. 1999 84:2700 2704.
76. Ushiroyama T, Ikeda A, Ueki M. Effect of continuous combined therapy with vitamin K(2) and vitamin D(3) on bone mineral density and coagulofibrinolysis function in postmenopausal women. Maturitas. 2002 41:211 221.
77. Sato Y, Honda Y, Kuno H, Oizumi K. Menatetrenone ameliorates osteopenia in disuse-affected limbs of vitamin D- and K-deficient stroke patients. Bone. 1998 23:291 296.
78. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006 166:1256 1261.
79. 3 on prednisolone-induced loss of bone mineral density in the lumbar spine. Am J Kidney Dis. 2004 43:53 60.
80. Jie KG, Bots ML, Vermeer C, Witteman JC, Grobbee DE. Vitamin K status and bone mass in women with and without aortic atherosclerosis: a population-based study. Calcif Tissue Int. 1996 59:352 356.
81. Tamura T, Morgan SL, Takimoto H. Vitamin K and the prevention of fractures. Arch Intern Med. 2007 167:94 author reply 94-95.
82. 1 intake on bone mineral density and fracture risk in perimenopausal women. Osteoporos Int. 2006 17:1122 1132.
83. Szulc P, Chapuy MC, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin is a marker of the risk of hip fracture: a three year follow-up study. Bone. 1996 18:487 488.
84. Szulc P, Arlot M, Chapuy MC, Duboeuf F, Meunier PJ, Delmas PD. Serum undercarboxylated osteocalcin correlates with hip bone mineral density in elderly women. J Bone Miner Res. 1994 9:1591 1595.
85. Knapen MH, Nieuwenhuijzen Kruseman AC, Wouters RS, Vermeer C. Correlation of serum osteocalcin fractions with bone mineral density in women during the first 10 years after menopause. Calcif Tissue Int. 1998 63:375 379.
86. Schaafsma A, Muskiet FA, Storm H, Hofstede GJ, Pakan I, Van der Veer E. Vitamin D(3) and vitamin K(1) supplementation of Dutch postmenopausal women with normal and low bone mineral densities: effects on serum 25-hydroxyvitamin D and carboxylated osteocalcin. Eur J Clin Nutr. 2000 54:626 631.
87. Booth SL, Broe KE, Peterson JW, et al. Associations between vitamin K biochemical measures and bone mineral density in men and women. J Clin Endocrinol Metab. 2004 89:4904 4909.